Stocks · News reference
Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cycle highs.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
As the week draws to a close, let’s take a look at some of the top stories that made headlines in the world of Apple Inc. (NASDAQ:AAPL). Congressman Who Bought Over $1 Million In Apple Stock Isn’t Selling With Tim
Foxconn expects stronger third-quarter results as rising demand and seasonal electronics sales boost its business.
Wyden and Harrigan are questioning whether the U.S. military has done enough to protect troops from commercial location tracking.
A congressman is buying up more Apple stock, even with a major CEO transition happening this month.
The article covers various investment themes and sectors including robotics and AI adoption, pharmaceuticals driven by aging populations, airline industry opportunities, and oil/natural gas earnings growth. It also discusses employment data showing Leisure & Hospitality leading job growth, and provides analysis of major tech companies like Amazon, AbbVie, and Alibaba facing different growth drivers and challenges.
AbbVie has successfully diversified beyond its blockbuster Humira with strong immunology drugs (Skyrizi and Rinvoq), while Pfizer is leveraging its cash position to build oncology and GLP-1 pipelines. Despite AbbVie's stronger growth trajectory, Pfizer offers better valuation metrics with lower P/E and P/S ratios, making it the preferred choice for long-term value investors willing to wait for new product launches.